ONCT
Oncternal Therapeutics Inc
Halal Rating :
Last Price
$0.57
Last updated:
Market Cap
-
7D Change
4.01%
1 Year Change
33.59%
Company Overview
Industries
Exchange
Next Earnings Date
Oncternal Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel oncology therapies. The company is dedicated to the development of innovative treatments for patients with various types of cancer. Their primary focus is on developing targeted therapies that address specific molecular targets and pathways involved in cancer progression.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $494000.0 | $9.18m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $801000.0 | $9.66m | - | - | 0.00% | 0.00% |
| March 31, 2024 | $569000.0 | $9.35m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Oncternal Therapeutics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.